Biogen announces $877mn acquisition of Nightstar Therapeutics

By hotmaillogin

Massachusetts-based multinational biotechnology company Biogen announced today that it has entered into an agreement with Nightstar Therapeutics, a clinical-stage gene therapy company based in London. The deal will see Biogen pay US$25 for each share of Nightstar, for a total transaction value of approximately $877mn.

Nightstar specializes in the design, testing and manufacture of gene therapies, which use artificially manipulated viruses in order to deliver genetic material into patients’ tissue, potentially treating or curing hereditary conditions. Nightstar’s research is focused on treatments in the field of Ophthalmology.

“Ophthalmology is an emerging growth area for Biogen,” said Michel Vounatsos, Biogen’s chief executive officer. “Nightstar would accelerate our entry into ophthalmology by contributing two mid- to late-stage gene therapy assets.”

SEE ALSO: 

David Fellows, Chief Executive Officer of Nightstar, said: “Our agreement with Biogen will give us the platform and resources to expand our mission to maintain and restore sight in patients with inherited retinal diseases. This transaction accelerates treatment to patients through Nightstar’s key retinal gene therapy programs that modify or halt progression of blindness. Together, with Biogen’s expertise in rare diseases, worldwide reach and extensive resources, we will dramatically improve the lives of patients around the world who currently have no treatment options. We are proud of what Nightstar has accomplished, and we thank our team for their tireless work to improve the lives of our patients and their families.”

The deal is expected to close in the second half of 2019.

Share

Featured Articles

Rise of the Chief Information Security Officer (CISO)

HE Dr Mohamed Al-Kuwaiti, Head of Cyber Security, UAE Government and Dr Aloysius Cheang, Chief Security Officer Huawei UAE, on the new age of the CISO

UAE building cybersecurity fortress for a safer world

Exclusive: His Excellency Dr Mohamed Al-Kuwaiti, Head of Cyber Security, UAE Government, on bold plans to build the world’s most secure digital society

The future of cybersecurity must be built on the basics

HE Dr Mohamed Al-Kuwaiti, Head of Cyber Security, UAE Government and Dr Aloysius Cheang, Chief Security Officer Huawei UAE, on the future of cybersecurity

10 of the best speakers at Procurement & Supply Chain LIVE

Leadership & Strategy

10 apps to support staff on World Mental Health Day

Leadership & Strategy

DEI done right: Brook Sims, COO, MAC Diversity Recruiters

Leadership & Strategy